[1]
Pavlidakey GP, Hashimoto K, Blum D. Yellow nail syndrome. Journal of the American Academy of Dermatology. 1984 Sep:11(3):509-12
[PubMed PMID: 6384296]
[2]
Vignes S, Baran R. Yellow nail syndrome: a review. Orphanet journal of rare diseases. 2017 Feb 27:12(1):42. doi: 10.1186/s13023-017-0594-4. Epub 2017 Feb 27
[PubMed PMID: 28241848]
[3]
SAMMAN PD, WHITE WF. THE "YELLOW NAIL" SYNDROME. The British journal of dermatology. 1964 Apr:76():153-7
[PubMed PMID: 14140738]
[5]
Nordkild P, Kromann-Andersen H, Struve-Christensen E. Yellow nail syndrome--the triad of yellow nails, lymphedema and pleural effusions. A review of the literature and a case report. Acta medica Scandinavica. 1986:219(2):221-7
[PubMed PMID: 3962735]
Level 3 (low-level) evidence
[6]
Preston A, Altman K, Walker G. Yellow nail syndrome. Proceedings (Baylor University. Medical Center). 2018 Oct:31(4):526-527. doi: 10.1080/08998280.2018.1487662. Epub 2018 Sep 26
[PubMed PMID: 30949001]
[7]
Maldonado F, Tazelaar HD, Wang CW, Ryu JH. Yellow nail syndrome: analysis of 41 consecutive patients. Chest. 2008 Aug:134(2):375-381. doi: 10.1378/chest.08-0137. Epub 2008 Apr 10
[PubMed PMID: 18403655]
[8]
Baran R, Pigmentations of the nails (chromonychia). The Journal of dermatologic surgery and oncology. 1978 Mar;
[PubMed PMID: 632390]
[9]
Stosiek N, Peters KP, Hiller D, Riedl B, Hornstein OP. Yellow nail syndrome in a patient with mycosis fungoides. Journal of the American Academy of Dermatology. 1993 May:28(5 Pt 1):792-4
[PubMed PMID: 8496432]
[10]
Valdés L, Huggins JT, Gude F, Ferreiro L, Alvarez-Dobaño JM, Golpe A, Toubes ME, González-Barcala FJ, José ES, Sahn SA. Characteristics of patients with yellow nail syndrome and pleural effusion. Respirology (Carlton, Vic.). 2014 Oct:19(7):985-92. doi: 10.1111/resp.12357. Epub 2014 Aug 14
[PubMed PMID: 25123563]
[11]
Woodfield G, Nisbet M, Jacob J, Mok W, Loebinger MR, Hansell DM, Wells AU, Wilson R. Bronchiectasis in yellow nail syndrome. Respirology (Carlton, Vic.). 2017 Jan:22(1):101-107. doi: 10.1111/resp.12866. Epub 2016 Aug 23
[PubMed PMID: 27551950]
[12]
Piraccini BM,Urciuoli B,Starace M,Tosti A,Balestri R, Yellow nail syndrome: clinical experience in a series of 21 patients. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG. 2014 Feb;
[PubMed PMID: 24134631]
[13]
Bull RH, Fenton DA, Mortimer PS. Lymphatic function in the yellow nail syndrome. The British journal of dermatology. 1996 Feb:134(2):307-12
[PubMed PMID: 8746347]
[14]
Kayıran O, De La Cruz C, Tane K, Soran A. Lymphedema: From diagnosis to treatment. Turkish journal of surgery. 2017:33(2):51-57. doi: 10.5152/turkjsurg.2017.3870. Epub 2017 Jun 1
[PubMed PMID: 28740950]
[15]
Yu H. Management of pleural effusion, empyema, and lung abscess. Seminars in interventional radiology. 2011 Mar:28(1):75-86. doi: 10.1055/s-0031-1273942. Epub
[PubMed PMID: 22379278]
[16]
Maldonado F, Ryu JH. Yellow nail syndrome. Current opinion in pulmonary medicine. 2009 Jul:15(4):371-5. doi: 10.1097/MCP.0b013e32832ad45a. Epub
[PubMed PMID: 19373089]
Level 3 (low-level) evidence
[17]
Decker A, Daly D, Scher RK. Role of Titanium in the Development of Yellow Nail Syndrome. Skin appendage disorders. 2015 Mar:1(1):28-30. doi: 10.1159/000375171. Epub 2015 Feb 11
[PubMed PMID: 27172293]
[18]
Itagaki H, Katuhiko S. Yellow nail syndrome following multiple orthopedic surgeries: a case report. Journal of medical case reports. 2019 Jul 1:13(1):200. doi: 10.1186/s13256-019-2136-2. Epub 2019 Jul 1
[PubMed PMID: 31256758]
Level 3 (low-level) evidence
[19]
Berglund F, Carlmark B. Titanium, sinusitis, and the yellow nail syndrome. Biological trace element research. 2011 Oct:143(1):1-7. doi: 10.1007/s12011-010-8828-5. Epub 2010 Sep 1
[PubMed PMID: 20809268]
[20]
Sarmast H, Takriti A. Yellow nail syndrome resulting from cardiac mitral valve replacement. Journal of cardiothoracic surgery. 2019 Apr 11:14(1):72. doi: 10.1186/s13019-019-0903-1. Epub 2019 Apr 11
[PubMed PMID: 30971303]
[21]
Wells GC. Yellow nail syndrome: with familiar primary hypoplasia of lymphatics, manifest late in life. Proceedings of the Royal Society of Medicine. 1966 May:59(5):447
[PubMed PMID: 5933133]
[23]
Gupta S, Samra D, Yel L, Agrawal S. T and B cell deficiency associated with yellow nail syndrome. Scandinavian journal of immunology. 2012 Mar:75(3):329-35. doi: 10.1111/j.1365-3083.2011.02653.x. Epub
[PubMed PMID: 21995335]
[24]
Siegelman SS, Heckman BH, Hasson J. Lymphedema, pleural effusions and yellow nails: associated immunologic deficiency. Diseases of the chest. 1969 Aug:56(2):114-7
[PubMed PMID: 5822545]
[25]
Yalçin E, Doğru D, Gönç EN, Cetinkaya A, Kiper N. Yellow nail syndrome in an infant presenting with lymphedema of the eyelids and pleural effusion. Clinical pediatrics. 2004 Jul-Aug:43(6):569-72
[PubMed PMID: 15248011]
[26]
Cebeci F, Celebi M, Onsun N. Nonclassical yellow nail syndrome in six-year-old girl: a case report. Cases journal. 2009 Oct 24:2():165. doi: 10.1186/1757-1626-2-165. Epub 2009 Oct 24
[PubMed PMID: 19946476]
Level 3 (low-level) evidence
[27]
Jayaraj A, Raju S, May C, Pace N. The diagnostic unreliability of classic physical signs of lymphedema. Journal of vascular surgery. Venous and lymphatic disorders. 2019 Nov:7(6):890-897. doi: 10.1016/j.jvsv.2019.04.013. Epub 2019 Jul 4
[PubMed PMID: 31281100]
[29]
Novis SJ, Akkina SR, Lynn S, Kern HE, Keshavarzi NR, Pynnonen MA. A diagnostic dilemma: chronic sinusitis diagnosed by non-otolaryngologists. International forum of allergy & rhinology. 2016 May:6(5):486-90. doi: 10.1002/alr.21691. Epub 2016 Jan 11
[PubMed PMID: 26750399]
[30]
Iqbal M, Rossoff LJ, Marzouk KA, Steinberg HN. Yellow nail syndrome: resolution of yellow nails after successful treatment of breast cancer. Chest. 2000 May:117(5):1516-8
[PubMed PMID: 10807848]
[31]
Brooks KG, Echevarria C, Cooper D, Bourke SC. Case-based discussion from North Tyneside General Hospital: somatostatin analogues in yellow nail syndrome associated with recurrent pleural effusions. Thorax. 2014 Oct:69(10):967-8. doi: 10.1136/thoraxjnl-2014-205426. Epub 2014 Jun 12
[PubMed PMID: 24923874]
Level 3 (low-level) evidence
[32]
Norton L. Further observations on the yellow nail syndrome with therapeutic effects of oral alpha-tocopherol. Cutis. 1985 Dec:36(6):457-62
[PubMed PMID: 4075838]
[33]
Tosti A, Piraccini BM, Iorizzo M. Systemic itraconazole in the yellow nail syndrome. The British journal of dermatology. 2002 Jun:146(6):1064-7
[PubMed PMID: 12072079]
[34]
Abell E, Samman PD. Yellow nail syndrome treated by intralesional triamcinolone acetonide. The British journal of dermatology. 1973 Feb:88(2):200-1
[PubMed PMID: 4706464]
[35]
Arroyo JF, Cohen ML. Improvement of yellow nail syndrome with oral zinc supplementation. Clinical and experimental dermatology. 1993 Jan:18(1):62-4
[PubMed PMID: 8440057]
[36]
Suzuki M, Yoshizawa A, Sugiyama H, Ichimura Y, Morita A, Takasaki J, Naka G, Hirano S, Izumi S, Takeda Y, Hoji M, Kobayashi N, Kudo K. A case of yellow nail syndrome with dramatically improved nail discoloration by oral clarithromycin. Case reports in dermatology. 2011 Sep:3(3):251-8. doi: 10.1159/000334734. Epub 2011 Nov 30
[PubMed PMID: 22220146]
Level 3 (low-level) evidence
[37]
International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema: 2013 Consensus Document of the International Society of Lymphology. Lymphology. 2013 Mar:46(1):1-11
[PubMed PMID: 23930436]
Level 3 (low-level) evidence
[38]
Dallmann A, Attanoos RL. Yellow Nail Syndrome with Bilateral Pleural Plaques and Diffuse Pleural Thickening: A Mimic of Asbestos Related Disease. Case reports in pulmonology. 2018:2018():7302898. doi: 10.1155/2018/7302898. Epub 2018 Sep 24
[PubMed PMID: 30345138]
Level 3 (low-level) evidence
[39]
Porcel JM. Pleural effusions from congestive heart failure. Seminars in respiratory and critical care medicine. 2010 Dec:31(6):689-97. doi: 10.1055/s-0030-1269828. Epub 2011 Jan 6
[PubMed PMID: 21213200]
[40]
Kaur R, Kashyap B, Bhalla P. Onychomycosis--epidemiology, diagnosis and management. Indian journal of medical microbiology. 2008 Apr-Jun:26(2):108-16
[PubMed PMID: 18445944]
[41]
Daniels CE, Ryu JH. Improving the safety of thoracentesis. Current opinion in pulmonary medicine. 2011 Jul:17(4):232-6. doi: 10.1097/MCP.0b013e328345160b. Epub
[PubMed PMID: 21346571]
Level 3 (low-level) evidence
[42]
Eid AA, Keddissi JI, Kinasewitz GT. Hypoalbuminemia as a cause of pleural effusions. Chest. 1999 Apr:115(4):1066-9
[PubMed PMID: 10208209]
[43]
Okajima S, Hirota A, Kimura E, Inagaki M, Tamai N, Iizaka S, Nakagami G, Mori T, Sugama J, Sanada H. Health-related quality of life and associated factors in patients with primary lymphedema. Japan journal of nursing science : JJNS. 2013 Dec:10(2):202-11. doi: 10.1111/j.1742-7924.2012.00220.x. Epub 2012 Jul 3
[PubMed PMID: 24373443]
Level 2 (mid-level) evidence
[45]
Ayata A, Unal M, Ersanli D, Bilge AH. Ocular findings in yellow nail syndrome. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie. 2008 Aug:43(4):493-4. doi: 10.3129/i08-068. Epub
[PubMed PMID: 18711477]
[46]
Bauer MA, Bauer KF. "You have a syndrome"-words you don't want to hear from a doctor. Battling yellow nail syndrome. Annals of the American Thoracic Society. 2014 Nov:11(9):1476-9. doi: 10.1513/AnnalsATS.201408-403OR. Epub
[PubMed PMID: 25422998]